U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C17H17N3O
Molecular Weight 279.3364
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 1-KETOMIRTAZAPINE

SMILES

CN1CCN2C(C1=O)C3=CC=CC=C3CC4=CC=CN=C24

InChI

InChIKey=NWXITVQAKIFZLZ-UHFFFAOYSA-N
InChI=1S/C17H17N3O/c1-19-9-10-20-15(17(19)21)14-7-3-2-5-12(14)11-13-6-4-8-18-16(13)20/h2-8,15H,9-11H2,1H3

HIDE SMILES / InChI
Molecular Formula C17H17N3O
Molecular Weight 279.3364
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Approval Year

Unknown
149124
Substance Class Chemical
Created
by admin
on Tue Apr 01 16:26:29 GMT 2025
Edited
by admin
on Tue Apr 01 16:26:29 GMT 2025
Record UNII
BMP2ZTF566
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
1-OXO MIRTAZAPINE
Preferred Name English
1-KETOMIRTAZAPINE
Common Name English
3,4,10,14B-TETRAHYDRO-2-METHYLPYRAZINO(2,1-A)PYRIDO(2,3-C)(2)BENZAZEPIN-1(2H)-ONE
Systematic Name English
MIRTAZAPINE IMPURITY C [EP IMPURITY]
Common Name English
PYRAZINO(2,1-A)PYRIDO(2,3-C)(2)BENZAZEPIN-1(2H)-ONE, 3,4,10,14B-TETRAHYDRO-2-METHYL-
Systematic Name English
Code System Code Type Description
RS_ITEM_NUM
1444241
Created by admin on Tue Apr 01 16:26:29 GMT 2025 , Edited by admin on Tue Apr 01 16:26:29 GMT 2025
PRIMARY
EPA CompTox
DTXSID40676086
Created by admin on Tue Apr 01 16:26:29 GMT 2025 , Edited by admin on Tue Apr 01 16:26:29 GMT 2025
PRIMARY
CAS
191546-96-0
Created by admin on Tue Apr 01 16:26:29 GMT 2025 , Edited by admin on Tue Apr 01 16:26:29 GMT 2025
PRIMARY
PUBCHEM
46782643
Created by admin on Tue Apr 01 16:26:29 GMT 2025 , Edited by admin on Tue Apr 01 16:26:29 GMT 2025
PRIMARY
FDA UNII
BMP2ZTF566
Created by admin on Tue Apr 01 16:26:29 GMT 2025 , Edited by admin on Tue Apr 01 16:26:29 GMT 2025
PRIMARY
Related Record Type Details
Structure of MIRTAZAPINE
PARENT -> IMPURITY
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
Structure of MIRTAZAPINE
PARENT -> IMPURITY
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966